|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.74/0.05
|
企业价值
2.85B
|
资产负债 |
每股账面净值
14.74
|
现金流量 |
现金流量率
0.02
|
损益表 |
收益
361.05M
|
每股收益
4.47
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/11/16 10:05 EST
同行比较之报价最少15分钟延迟
业务概览
|
|||
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others. |